CPT copyright 2010 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.The following Q&A comes from ...
The growth of the Medicare Advantage (MA) program to over half of eligible Medicare beneficiaries has made MA payment a salient part of Medicare policy discussions. Those discussions often focus on ...
395 new diagnosis codes have been proposed by CMS for fiscal year 2024. CMS recently released the fiscal year 2024 inpatient prospective payment system proposed rule, and with it came the annual ...
CMS isn’t just tweaking ASC policies in 2026; it’s remolding the financial and regulatory foundation of outpatient surgery. From a major expansion of procedures allowed in the setting to the phaseout ...
As a result of insurers “upcoding” patient diagnoses, the Centers for Medicare and Medicaid Services (CMS) overpaid Medicare Advantage (MA) by $50 billion (or 13 percent) in 2024, according to the ...
The fiscal year 2024 ICD-10-CM codes are now effective, and they will impact your reimbursement. Earlier this year, CMS announced the addition of 395 new diagnosis codes, 25 deletions to the diagnosis ...
A new study published in JAMA found that a new Medicare add-on billing code boosted pay significantly for specialists. The study analyzed Medicare claims data from 2024, the first year that the G22111 ...
Inspire Medical Systems recently reported a strong fourth quarter of 2025, with revenue rising 12.2% year on year and early commercial feedback on its next-generation Inspire V neurostimulator ...
Responding to criticisms lodged against an otherwise popular program among seniors, Senators Bill Cassidy, M.D. (R-LA) and Jeff Merkley (D-OR) introduced a bill to improve the way Medicare Advantage ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
CMS has released several fact sheets in recent weeks on billing and coding to provide guidance to healthcare organizations testing and treating patients for COVID-19, the disease caused by the novel ...
SAN RAFAEL, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results